课题基金 / 基金详情

Viral and Host Determinants of Cognitive Status in Vertically Transmitted HIV

Viral and Host Determinants of Cognitive Status in Vertically Transmitted HIV
垂直传播艾滋病毒认知状态的病毒和宿主决定因素
批准号:
9248128
负责人:
Robert H Paul
金额:
$72.99万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-22 至 2021-11-30

项目摘要

项目成果

Robert H Paul的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要-摘要 拟议研究的目的是对艾滋病毒宿主和病毒动态进行受控调查。 应用稳定联合抗逆转录病毒治疗(CART)的垂直感染儿童的脑完整性 缅甸。东南亚的预测试验结果显示残留的认知障碍 在有垂直感染的儿童HIV+个体中。社会经济变量预测认知测试 受感染儿童和暴露于艾滋病毒但未感染病毒的儿童的表现。努力 要确定艾滋病毒的神经发病机制,需要对这些环境变量进行充分的控制 已知会影响ADL的认知测试成绩和参与度。大多数HIV+儿童 在缅甸,居住在私人资助的孤儿院,有标准化的照顾者身份、营养和 教育。我们的初步工作显示,这些接受CART治疗的CD4水平高的儿童存在认知障碍 当与人口统计学上匹配的健康对照(HIV-)相比时,这一数字。此外,40%的艾滋病毒+ 儿童优先使用CXCR4共受体,认知障碍程度为 与表达CCR5共同受体的儿童相比,尽管这些儿童的CD4相似,但这些儿童的CD4水平更高 算了。以前的研究已经将CXCR4的使用与HIV+成年人的认知障碍联系在一起 晚期疾病,但从这些研究中尚不清楚共同受体亚型是否类似于认知 损害,或者更简单地说,是疾病严重程度和认知损害之间的相关变量。我们的 初步数据表明,CXCR4在降低大脑完整性方面发挥了机械性作用,独立于 晚期疾病,强调需要确定相关的免疫因素。从我们的工作 研究小组先前证明了循环单核细胞HIV含量、单核细胞亚群和 髓系免疫介质是HIV相关神经认知的关键机制 减损。本研究将研究这些免疫学机制和共同受体的趋向性。 在与垂直感染青年的认知障碍相关的一连串事件中。此信息是 对促进发展改善儿童认知功能的有针对性的治疗至关重要 感染了垂直感染的艾滋病毒。我们将招收120名HIV+垂直感染的儿童和青少年 在8岁到15岁之间和60岁之间--与人口统计学相匹配的艾滋病毒对照组,所有人都居住在 私人资助的孤儿院。将完成神经心理学、病毒学和免疫学分析。 在稳定CART的背景下确定儿童HIV神经发病机制。
英文摘要
PROJECT SUMMARY-ABSTRACT The purpose of the proposed study is conduct a controlled investigation of HIV host and viral dynamics on brain integrity in vertically infected children on stable combined antiretroviral therapy (cART) in Myanmar. Outcomes from the PREDICT trial in Southeast Asia revealed residual cognitive impairment among pediatric HIV+ individuals with vertical infection. Socioeconomic variables predicted cognitive test performance among infected children and children exposed to HIV but uninfected with the virus. Efforts to define the neuropathogenesis of HIV require adequate control of these environmental variables known to influence cognitive test performance and engagement in ADLs. The majority of HIV+ children in Myanmar reside in privately funded orphanages with standardized caregiver status, nutrition, and education. Our preliminary work reveals cognitive impairment in these children on cART with high CD4 count when compared to demographically matched healthy controls (HIV-). Further, 40% of the HIV+ children express preferential use of the CXCR4 co-receptor and the degree of cognitive impairment is greater among these children compared to those expressing the CCR5 co-receptor despite similar CD4 counts. Previous studies have associated CXCR4 utilization with worse cognition in HIV+ adults with advanced disease, but it is unclear from these studies if co-receptor subtype is liked to cognitive impairment or more simply a correlated variable between disease severity and cognitive impairment. Our preliminary data suggests a mechanistic role for CXCR4 on reduced brain integrity independent of advanced disease, emphasizing the need to identify the relevant immunological factors. Work from our team previously demonstrated that circulating monocyte HIV content, monocyte subpopulations, and myeloid-derived immunological mediators are key mechanisms of HIV-associated neurocognitive impairment. The present study will examine these immunological mechanisms and co-receptor tropism in the cascade of events related to cognitive impairment in vertically infected youth. This information is critical to facilitate the development of targeted treatments to improve cognitive function among children with vertically infected HIV. We will enroll 120 HIV+ vertically infected children and adolescents between the ages of 8 and 15 and 60 HIV- controls matched for demographics, and all residing in privately funded orphanages. Neuropsychological, virological, and immunological assays will be completed to determine pediatric HIV neuropathogenesis in the context of stable cART.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Longitudinal determination of nervous system consequences of SARS-CoV-2 in virologically suppressed people with HIV-1 treated in early infection
  • 批准号:
    10613789
  • 项目类别:
  • 资助金额:
    $324.99万
  • 财政年份:
    2022
  • 负责人:
    Robert H Paul
  • 依托单位:
Mental Health and Cognition in HIV Infection in Rakai Uganda
  • 批准号:
    10663076
  • 项目类别:
  • 资助金额:
    $57.85万
  • 财政年份:
    2019
  • 负责人:
    Robert H Paul
  • 依托单位:
Mental Health and Cognition in HIV Infection in Rakai Uganda
  • 批准号:
    10252860
  • 项目类别:
  • 资助金额:
    $58.36万
  • 财政年份:
    2019
  • 负责人:
    Robert H Paul
  • 依托单位:
Mental Health and Cognition in HIV Infection in Rakai Uganda
  • 批准号:
    10000143
  • 项目类别:
  • 资助金额:
    $58.01万
  • 财政年份:
    2019
  • 负责人:
    Robert H Paul
  • 依托单位:
海外基金